These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 87373
1. Anti-allergic activities of a new benzopyranopyridine derivative Y-12,141 in rats. Goto K, Terasawa M, Maruyama Y. Int Arch Allergy Appl Immunol; 1979; 59(1):13-9. PubMed ID: 87373 [Abstract] [Full Text] [Related]
4. Anti-anaphylactic activities of a new benzopyranopyridine derivative Y-12,141 in rats and guinea pigs. Goto K, Terasawa M, Kadobe Y, Maruyama Y. Jpn J Pharmacol; 1980 Aug; 30(4):537-47. PubMed ID: 6162988 [Abstract] [Full Text] [Related]
5. Inhibitory effect of traxanox sodium on IgE-mediated histamine release from passively-sensitized mast cells of the rat in vitro. Goto K, Hisadome M, Terasawa M. Int Arch Allergy Appl Immunol; 1982 Aug; 68(4):332-7. PubMed ID: 6178699 [Abstract] [Full Text] [Related]
7. Potent inhibitory activity of HSR-6071, a new antiallergic agent, on passive cutaneous anaphylaxis (PCA). Makino E, Ohashi T, Takahashi H, Kato H, Ito Y, Nagai H, Koda A, Azuma H. Jpn J Pharmacol; 1990 Jan; 52(1):87-94. PubMed ID: 1689783 [Abstract] [Full Text] [Related]
8. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions. Shin HY, Kim JS, An NH, Park RK, Kim HM. Life Sci; 2004 Apr 23; 74(23):2877-87. PubMed ID: 15050425 [Abstract] [Full Text] [Related]
9. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models. Kobayashi K, Hiroi J, Kishi S, Sawase K, Hirayama Y, Chihara S, Imai T, Shigi Y, Shimomura K, Kohsaka M. Jpn J Pharmacol; 1993 Sep 23; 63(1):73-81. PubMed ID: 7505860 [Abstract] [Full Text] [Related]
10. Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines. Musser JH, Jones H, Sciortino S, Bailey K, Coutts SM, Khandwala A, Sonnino-Goldman P, Leibowitz M, Wolf P, Neiss ES. J Med Chem; 1985 Sep 23; 28(9):1255-9. PubMed ID: 2411926 [Abstract] [Full Text] [Related]
14. [The pharmacological properties of a new anti-allergic agent, KP-136, in cutaneous models]. Kuriyama K, Hiyama Y, Ito K, Ichikawa K, Kitada S, Yoshinaka I. Nihon Yakurigaku Zasshi; 1987 Apr 23; 89(4):213-24. PubMed ID: 2440785 [Abstract] [Full Text] [Related]
15. Inhibition of immediate hypersensitivity reactions in the rat by disodium cromoglycate and nitroindanedione. Spicer BA, Ross JW, Smith H. Clin Exp Immunol; 1975 Sep 23; 21(3):419-29. PubMed ID: 812623 [Abstract] [Full Text] [Related]
16. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release. Khandwala A, Coutts S, Pruss T, Jones H, Neiss E, Weinryb I. Biochem Pharmacol; 1987 Mar 01; 36(5):663-72. PubMed ID: 2435293 [Abstract] [Full Text] [Related]
17. Inhibition of allergic reactions by cromoglycate and by a new anti-allergy drug U-42,585E. I. Activity in rats. Johnson HG, VanHout CA, Wright JB. Int Arch Allergy Appl Immunol; 1978 Mar 01; 56(5):416-23. PubMed ID: 75851 [Abstract] [Full Text] [Related]
20. Effect of butyl 3-(1H-tetrazol-5-Yl) oxanilate (MTB) on immunological or non-immunological histamine and SRS(-A) release from guinea-pig, monkey and human lung tissue. Hashimoto T, Kohno SW, Ohata K, Yanagihara Y, Shida T. Jpn J Pharmacol; 1987 Aug 01; 44(4):447-53. PubMed ID: 2446036 [Abstract] [Full Text] [Related] Page: [Next] [New Search]